← Leaderboards
William Hildebrand
University Of Oklahoma Hlth Sciences Ctr
$12,770,557
Attributed
$19,170,761
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,381,124 · 7
FDA$789,637 · 1
By mechanism
R01$11,951,627 · 3
U01$6,124,035 · 2
N01$660,407 · 2
R21$434,692 · 1
Top collaborators
- Shaying Zhao7 shared
- Erin June Adams5 shared
- David M. Lewinsohn5 shared
- Lewis L. Lanier2 shared
Most similar at University Of Oklahoma Hlth Sciences Ctr
Same institution · by research overlap
- Youngjae You$4,324,163
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsProteinsSamplingMass Spectrum AnalysisPeptidesComplexImmune SystemInfectionResponseT-LymphocytePeptide FragmentsT-Cell ReceptorBindingCollaborationsAntigensMolecularStructurePublishingTranslatingVaccinationAllelesPeripheral Blood Mononuclear CellPathogenMajor Histocompatibility Complex
Grant awards (28)
Canine MHC-I genotyping and tumor specific neoantigen determination$459,611
R01 · FY2025 · CA
Canine MHC-I genotyping and tumor specific neoantigen determination$436,631
R01 · FY2024 · CA
AI Transfer of the MHC-I Immunopeptidome from Human to Dog$158,559
R01 · FY2024 · CA
T cell recognition of the MR1 presented microbial metabolome$1,836,140
R01 · FY2023 · AI
Canine MHC-I genotyping and tumor specific neoantigen determination$462,701
R01 · FY2023 · CA
rPIV5- and AVLP-vectored vaccine development with public tumor-specific neoantigens$146,672
R01 · FY2023 · CA
T cell recognition of the MR1 presented microbial metabolome$1,340,169
R01 · FY2022 · AI
Canine MHC-I genotyping and tumor specific neoantigen determination$450,417
R01 · FY2022 · CA
T cell recognition of the MR1 presented microbial metabolome$1,346,843
R01 · FY2021 · AI
Canine MHC-I genotyping and tumor specific neoantigen determination$492,039
R01 · FY2021 · CA
T cell recognition of the MR1 presented microbial metabolome$1,362,106
R01 · FY2020 · AI
T cell recognition of the MR1 presented microbial metabolome$1,434,057
R01 · FY2019 · AI
Human natural killer cell recognition of cytomegalovirus$231,209
R21 · FY2015 · AI
Human natural killer cell recognition of cytomegalovirus$203,483
R21 · FY2014 · AI
Discovery and Targeting of West Nile Virus Epitopes$999,069
U01 · FY2013 · AI · contact PI
Discovery and Targeting of HIV-1 Associated Antigens$479,195
R01 · FY2013 · AI · contact PI
Direct Discovery of HLA-associated Influenza Epitopes$389,637
U01 · FY2013 · FD · contact PI
Discovery and Targeting of West Nile Virus Epitopes$1,159,715
U01 · FY2012 · AI · contact PI
Discovery and Targeting of HIV-1 Associated Antigens$509,781
R01 · FY2012 · AI · contact PI
Direct Discovery of HLA-associated Influenza Epitopes$400,000
U01 · FY2012 · FD · contact PI
Discovery and Targeting of West Nile Virus Epitopes$1,185,329
U01 · FY2011 · AI · contact PI
Discovery and Targeting of HIV-1 Associated Antigens$509,781
R01 · FY2011 · AI · contact PI
Discovery and Targeting of West Nile Virus Epitopes$1,193,045
U01 · FY2010 · AI · contact PI
Discovery and Targeting of HIV-1 Associated Antigens$526,925
R01 · FY2010 · AI · contact PI
Discovery and Targeting of West Nile Virus Epitopes$797,240
U01 · FY2009 · AI · contact PI
Direct Epitope Identification and Validation$300,000
N01 · FY2009 · AI · contact PI
BAA-APPLICATION OF HLA DATA TO DEVELOP &IMPROVE VACCINE$360,407
N01 · FY2000 · AI
BAA-APPLICATION OF HLA DATA TO DEVELOP &IMPROVE VACCINE$0
N01 · FY2000 · AI